相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis and biological evaluation of novel thiohydantoin derivatives as potent androgen receptor antagonists for the treatment of prostate cancer
Ao Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
Cora N. Sternberg
FUTURE ONCOLOGY (2019)
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
Tatsuo Sugawara et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Enzalutamide, apalutamide, or darolutamide: are apples or bananas best for patients?
Celestia Higano
NATURE REVIEWS UROLOGY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Biological Evolution of Castration-resistant Prostate Cancer
Alastair Davies et al.
EUROPEAN UROLOGY FOCUS (2019)
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer
David Y. Takeda et al.
CELL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Androgen synthesis in prostate cancer: do all roads lead to Rome?
Ryan Stuchbery et al.
NATURE REVIEWS UROLOGY (2017)
Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer
Bin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Structure of the homodimeric androgen receptor ligand-binding domain
Marta Nadal et al.
NATURE COMMUNICATIONS (2017)
Drug discovery in advanced prostate cancer: translating biology into therapy
Timothy A. Yap et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth
Yoshiaki Yamamoto et al.
CLINICAL CANCER RESEARCH (2015)
Genomic rearrangements in prostate cancer
Christopher E. Barbieri et al.
CURRENT OPINION IN UROLOGY (2015)
Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonists
Alexandre V. Ivachtchenko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Investigation of amino acid conjugates of (S)-1-[1-(4-aminobenzoyl)-2,3-dihydro-1H-indol-6-sulfonyl]-4-phenyl-imidazolidin-2-one (DW2282) as water soluble anticancer prodrugs
Ki-Cheul Lee et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Enzalutamide: A Novel Antiandrogen for Patients with Castrate-Resistant Prostate Cancer
Jean Hoffman-Censits et al.
CLINICAL CANCER RESEARCH (2013)
New Therapeutics to Treat Castrate-Resistant Prostate Cancer
Omer Acar et al.
SCIENTIFIC WORLD JOURNAL (2013)
An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
Manav Korpal et al.
CANCER DISCOVERY (2013)
A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
James D. Joseph et al.
CANCER DISCOVERY (2013)
Structure-Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
Michael E. Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Role of Androgen Receptor Mutations in Prostate Cancer Progression
G. N. Brooke et al.
CURRENT GENOMICS (2009)
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
William P. Harris et al.
NATURE CLINICAL PRACTICE UROLOGY (2009)
Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives
CS Chang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
J Holzbeierlein et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Asymmetric synthesis of 4,4-disubstituted-2-imidazoli-dinones:: Potent NK1 antagonists
GA Reichard et al.
ORGANIC LETTERS (2003)
The current state of hormonal therapy for prostate cancer
BA Hellerstedt et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2002)
分享论文
